174 related articles for article (PubMed ID: 37670372)
21. Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein.
Christensen BR; Rendo MJ; Beeler BW; Huddleston BJ; Fenderson JL
Cureus; 2022 Mar; 14(3):e23398. PubMed ID: 35481321
[TBL] [Abstract][Full Text] [Related]
22. Recurrent hypercalcemia due to ectopic production of parathyroid hormone-related protein and intact parathyroid hormone in a single patient with multiple malignancies.
Eid W; Wheeler TM; Sharma MD
Endocr Pract; 2004; 10(2):125-8. PubMed ID: 15256329
[TBL] [Abstract][Full Text] [Related]
23. 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma.
Rodríguez-Gutiérrez R; Zapata-Rivera MA; Quintanilla-Flores DL; Camara-Lemarroy CR; Lavalle-Gonzalez FJ; González-González JG; Villarreal-Pérez JZ
BMC Endocr Disord; 2014 Apr; 14():32. PubMed ID: 24721620
[TBL] [Abstract][Full Text] [Related]
24. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.
Nakajima K; Tamai M; Okaniwa S; Nakamura Y; Kobayashi M; Niwa T; Horigome N; Ito N; Suzuki S; Nishio S; Komatsu M
Endocr J; 2013; 60(5):557-62. PubMed ID: 23303131
[TBL] [Abstract][Full Text] [Related]
25. What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Ragni A; Zanata I; Colao A; Faggiano A
J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294693
[TBL] [Abstract][Full Text] [Related]
26. Humoral Hypercalcemia in Uterine Cancers: A Case Report and Literature Review.
Motilal Nehru V; Garcia G; Ding J; Kong F; Dai Q
Am J Case Rep; 2017 Jan; 18():22-25. PubMed ID: 28057913
[TBL] [Abstract][Full Text] [Related]
27. Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor.
Valdes-Socin H; Almanza MR; Fernández-Ladreda MT; Daele DV; Polus M; Chavez M; Beckers A
Arch Endocrinol Metab; 2017; 61(5):506-509. PubMed ID: 28977163
[TBL] [Abstract][Full Text] [Related]
28. Ovarian non-small cell neuroendocrine carcinoma with paraneoplastic parathyroid hormone-related hypercalcemia.
Ohira S; Itoh K; Shiozawa T; Horiuchi A; Ono K; Takeuchi H; Hosoda W; Konishi I
Int J Gynecol Pathol; 2004 Oct; 23(4):393-7. PubMed ID: 15381910
[TBL] [Abstract][Full Text] [Related]
29. Hypercalcemia from metastatic pancreatic neuroendocrine tumor secreting 1,25-dihydroxyvitamin D.
Zhu V; de Las Morenas A; Janicek M; Hartshorn K
J Gastrointest Oncol; 2014 Aug; 5(4):E84-7. PubMed ID: 25083313
[TBL] [Abstract][Full Text] [Related]
30. Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor: a case report.
Haemels M; Delaunoit T; Van Laere K; Van Cutsem E; Verslype C; Deroose CM
BMC Gastroenterol; 2020 Oct; 20(1):324. PubMed ID: 33008295
[TBL] [Abstract][Full Text] [Related]
31. Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature.
Brizzi MP; Sonetto C; Tampellini M; Di Maio M; Volante M; Scagliotti GV
BMC Cancer; 2015 Nov; 15():914. PubMed ID: 26582328
[TBL] [Abstract][Full Text] [Related]
32. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
[TBL] [Abstract][Full Text] [Related]
33. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
Sato K; Onuma E; Yocum RC; Ogata E
Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
[TBL] [Abstract][Full Text] [Related]
34. First report of ectopic ACTH syndrome and PTHrP-induced hypercalcemia due to a hepatoblastoma in a child.
Grunewald TG; von Luettichau I; Welsch U; Dörr HG; Höpner F; Kovacs K; Burdach S; Rabl W
Eur J Endocrinol; 2010 Apr; 162(4):813-8. PubMed ID: 20133447
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone-related protein (PTHrP) and malignancy.
Grunbaum A; Kremer R
Vitam Horm; 2022; 120():133-177. PubMed ID: 35953108
[TBL] [Abstract][Full Text] [Related]
36. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM).
Kobayashi N; Higurashi T; Iida H; Mawatari H; Endo H; Nozaki Y; Tomimoto A; Yoneda K; Akiyama T; Fujita K; Takahashi H; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Kubota K; Saito S; Ueno N; Nakajima A; Yamanaka S; Inayama Y
J Hepatobiliary Pancreat Surg; 2008; 15(5):531-5. PubMed ID: 18836809
[TBL] [Abstract][Full Text] [Related]
37. Hypercalcemia of Malignancy.
Malangone S; Campen CJ
J Adv Pract Oncol; 2015; 6(6):586-92. PubMed ID: 27648348
[TBL] [Abstract][Full Text] [Related]
38. Humoral hypercalcemia complicating adenocarcinoma of the sigmoid colon: report of a case.
Sakata J; Wakai T; Shirai Y; Sakata E; Hasegawa G; Hatakeyama K
Surg Today; 2005; 35(8):692-5. PubMed ID: 16034553
[TBL] [Abstract][Full Text] [Related]
39. Severe Hypercalcemia as the Initial Presentation of a Neuroendocrine Carcinoma of Unknown Primary Site: A Case Report.
Shaka H; Raghavan S
Cureus; 2019 Nov; 11(11):e6075. PubMed ID: 31832292
[TBL] [Abstract][Full Text] [Related]
40. The parathyroid hormone-related protein associated with malignancy is secreted by neuroendocrine tumors.
Deftos LJ; Gazdar AF; Ikeda K; Broadus AE
Mol Endocrinol; 1989 Mar; 3(3):503-8. PubMed ID: 2747656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
